Onterris looks like a mispriced environmental compounder, with temporary Q1 disruption masking durable regulatory tailwinds, proprietary PFAS technology, and a 5-year valuation path that materially exceeds today’s $22.08 share price.
Overview
Onterris, Inc. (NYSE: ONT), formerly Montrose Environmental Group, is a pure-play environmental solutions provider offering regulatory consulting, testing, remediation engineering, and proprietary water treatment technologies across North America and Australia. The April/May 2026 rebrand consolidated several acquired subsidiaries into one operating identity, which management believes will improve client engagement, labor utilization, and cross-selling. The company’s business is anchored by **high recurring revenue of 96%**, a diversified base of **more than 6,100 clients**, and differentiated PFAS treatment IP including ECT2 and FOAM-X. Long-term demand is supported by tightening PFAS and methane regulation, plus reshoring-led growth in semiconductor and pharmaceutical manufacturing. Financially, the near-term setup is mixed but improving. Q1 2026 revenue of **$168.5 million** declined 5.2% year over year due to weaker emergency response activity and severe winter weather, yet management reiterated full-year guidance of **$840 million to $900 million** revenue and **$125 million to $130 million** adjusted EBITDA. The stock sold off 20.68% after earnings, but the report argues this reaction overstates temporary issues. **Valuation appears discounted** at **1.32x forward EV/sales** and **8.97x forward EV/EBITDA**, despite structural growth, margin expansion potential, and a probability-weighted 5-year value of **$61.85** versus a current price of $22.08.